Samuel Baxter, MD
Adult Reconstructive Orthopaedic Surgery · Little Rock, ARNPI 1902292360
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $7,642 of the $10,865 with a category attached, or 70.3%. Medacta USA, Inc. accounts for 74.8% of it on its own, with 10 other manufacturers making up the rest.
Across 76 payments — averaging $142.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$8K
- Zimmer Biomet$2K
- Stryker$309
- Molnlycke Health Care US, LLC$224
- Next Science LLC$116
- Vertex$72
- plus $189 from 5 others
What the payments were for
- Consulting fees$5005%
- Travel & lodging$7,64270%
- Food & beverage$2,62324%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 41 | $8,122 |
| Zimmer Biomet | 15 | $1,833 |
| Stryker | 6 | $309 |
| Molnlycke Health Care US, LLC | 1 | $224 |
| Next Science LLC | 1 | $116 |
| Vertex | 3 | $72 |
| Johnson & Johnson | 3 | $45 |
| Innovation Technologies Inc | 2 | $45 |
| Heron Therapeutics, Inc. | 1 | $44 |
| Bioventus LLC | 2 | $32 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMISTEM$3,558
- GMK SPHERE$2,206
- Arcos$1,275
- AMIStem H Femoral Stems$846
- Mepilex Border Post Op$671
- SPHERIKA$508
- Mepilex Border Post Op AG$447
- MAKO$147
- ROSA$136
- GMK Sphere Revision System$129
- Xperience$116
- BlastX$116
- SurgX$116
How this compares
Too few adult reconstructive orthopaedic surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 183 | $1,121 |
| Celecoxib | 14 | $246 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $163 |
| Oxycodone Hcl | 31 | $152 |
| Methylprednisolone | 30 | $137 |
| Meloxicam | 21 | $101 |
| Amoxicillin | 43 | $48 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Little Rock
- David CollinsLittle Rock$2.4M
- Paul EdwardsLittle Rock$158K
- David NewbernLittle Rock$3K
- Adam NorwoodLittle Rock$1K
- Adam SmithLittle Rock$751
- Michael HusseyLittle Rock$436
- Charles HanbyFayetteville$81K
- Jonathan CreechFayetteville$35K
- Jon BanwartBentonville$5K
- Russell RaulsMountain Home$618
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.